Showing results (521-530 of 529) with videos related to
Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 529 results.
Cell|May 28, 2025
Cross-organ metabolite production and consumption in healthy and atherogenic conditionsHosung Bae, Sunhee Jung, Johnny Le, et al.Science (New York, N.Y.)|September 9, 2004
Macroscopic, neat, single-walled carbon nanotube fibersLars M Ericson, Hua Fan, Haiqing Peng, et al.Annals of Clinical and Translational Neurology|November 25, 2022
Associations of sNfL with clinico-radiological measures in a large MS populationElias S Sotirchos, Kathryn C Fitzgerald, Carol M Singh, et al.Frontiers in Neurology|August 28, 2020
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)Ellen M Mowry, Robert A Bermel, James R Williams, et al.FEMS Microbiology Ecology|January 13, 2021
Democratization of fungal highway columns as a tool to investigate bacteria associated with soil fungiPilar Junier, Guillaume Cailleau, Ilona Palmieri, et al.Biorxiv : the Preprint Server for Biology|September 2, 2025
Intestinal catabolism of dietary fructose promotes obesity and insulin resistance via ileal lacteal remodelingMiranda L Lopez, Taekyung Kang, Ana Espeleta, et al.Cancer Research|February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular CarcinomaRenée L Flaherty, Flavia Hughes, George Sflomos, et al.BMJ Open|June 11, 2018
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocolSybil A McAuley, Martin I de Bock, Vijaya Sundararajan, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)Emma C Tallantyre, Sarah M Planchon, Harriet Howard, et al.Pageof 53